Skip to main content

Antibiotics exposure and risk of inflammatory bowel disease: a systematic review.

Publication ,  Journal Article
Theochari, NA; Stefanopoulos, A; Mylonas, KS; Economopoulos, KP
Published in: Scandinavian journal of gastroenterology
January 2018

The aim of this study was to critically assess all available evidence suggesting an association between antibiotic exposure and new onset of inflammatory bowel disease (IBD).This systematic review was conducted according to the PRISMA statement and eligible studies were identified through search of PubMed, Embase and the Cochrane Library. Data on patient demographics, antibiotic exposure and confounding factors were analyzed. The Newcastle-Ottawa Scale (NOS) was used to assess the quality of eligible studies.A total of 15 observational studies (10 case control and five cohort) including 8748 patients diagnosed with IBD were systematically reviewed. Antibiotic exposure was mostly associated with Crohn's disease but not with ulcerative colitis. In particular, penicillin's, cephalosporins, metronidazole and fluoroquinolones were most commonly associated with the onset of Crohn's disease. The impact of tetracycline-family antibiotics on the pathogenesis of IBD was not clear.There may be an association between antibiotic exposure and the development of IBD; especially Crohn's disease. Even though, clinicians should be cautious when prescribing certain antibiotic regimens to patients with a strong family history of IBD, it should be emphasized that available data are not granular enough to reach any definitive conclusions.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Scandinavian journal of gastroenterology

DOI

EISSN

1502-7708

ISSN

0036-5521

Publication Date

January 2018

Volume

53

Issue

1

Start / End Page

1 / 7

Related Subject Headings

  • Tetracycline
  • Risk
  • Penicillins
  • Metronidazole
  • Humans
  • Gastroenterology & Hepatology
  • Fluoroquinolones
  • Crohn Disease
  • Colitis, Ulcerative
  • Anti-Bacterial Agents
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Theochari, N. A., Stefanopoulos, A., Mylonas, K. S., & Economopoulos, K. P. (2018). Antibiotics exposure and risk of inflammatory bowel disease: a systematic review. Scandinavian Journal of Gastroenterology, 53(1), 1–7. https://doi.org/10.1080/00365521.2017.1386711
Theochari, Nikoletta A., Anastasios Stefanopoulos, Konstantinos S. Mylonas, and Konstantinos P. Economopoulos. “Antibiotics exposure and risk of inflammatory bowel disease: a systematic review.Scandinavian Journal of Gastroenterology 53, no. 1 (January 2018): 1–7. https://doi.org/10.1080/00365521.2017.1386711.
Theochari NA, Stefanopoulos A, Mylonas KS, Economopoulos KP. Antibiotics exposure and risk of inflammatory bowel disease: a systematic review. Scandinavian journal of gastroenterology. 2018 Jan;53(1):1–7.
Theochari, Nikoletta A., et al. “Antibiotics exposure and risk of inflammatory bowel disease: a systematic review.Scandinavian Journal of Gastroenterology, vol. 53, no. 1, Jan. 2018, pp. 1–7. Epmc, doi:10.1080/00365521.2017.1386711.
Theochari NA, Stefanopoulos A, Mylonas KS, Economopoulos KP. Antibiotics exposure and risk of inflammatory bowel disease: a systematic review. Scandinavian journal of gastroenterology. 2018 Jan;53(1):1–7.

Published In

Scandinavian journal of gastroenterology

DOI

EISSN

1502-7708

ISSN

0036-5521

Publication Date

January 2018

Volume

53

Issue

1

Start / End Page

1 / 7

Related Subject Headings

  • Tetracycline
  • Risk
  • Penicillins
  • Metronidazole
  • Humans
  • Gastroenterology & Hepatology
  • Fluoroquinolones
  • Crohn Disease
  • Colitis, Ulcerative
  • Anti-Bacterial Agents